tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

OLMA Stock Latest News

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Press ReleasesOlema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
23d ago
OLMA
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Climbs on Promising Pipeline
PremiumMarket News
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Climbs on Promising Pipeline
2M ago
OLMA
3 Best Stocks to Buy Now, 6/5/2024, According to Top Analysts 
PremiumMarket News
3 Best Stocks to Buy Now, 6/5/2024, According to Top Analysts 
2M ago
EVLV
MRUS
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2M ago
OLMA
Olema Oncology price target raised to $30 from $21 at Oppenheimer
PremiumThe Fly
Olema Oncology price target raised to $30 from $21 at Oppenheimer
2M ago
PFE
OLMA
Olema Oncology to Participate in Upcoming Investor Conferences in June
PremiumPress ReleasesOlema Oncology to Participate in Upcoming Investor Conferences in June
2M ago
OLMA
Olema Oncology announces new data on palazestrant with ribociclib
PremiumThe Fly
Olema Oncology announces new data on palazestrant with ribociclib
2M ago
OLMA
Olema Pharmaceuticals Announces Promising Breast Cancer Trial Results
PremiumCompany Announcements
Olema Pharmaceuticals Announces Promising Breast Cancer Trial Results
2M ago
8K
OLMA
Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presented at the 2024 ESMO Breast Cancer Congress
PremiumPress Releases
Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presented at the 2024 ESMO Breast Cancer Congress
2M ago
OLMA
3 Best Stocks to Buy Now, 5/9/2024, According to Top Analysts 
PremiumMarket News
3 Best Stocks to Buy Now, 5/9/2024, According to Top Analysts 
3M ago
ALAB
CGON
Olema Oncology reports Q1 EPS (56c), consensus (55c)
PremiumThe Fly
Olema Oncology reports Q1 EPS (56c), consensus (55c)
3M ago
OLMA
Olema Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
PremiumPress Releases
Olema Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
3M ago
OLMA
Olema Oncology to present clinical data for palazestrant combination at ESMO
PremiumThe FlyOlema Oncology to present clinical data for palazestrant combination at ESMO
3M ago
OLMA
Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress
PremiumPress Releases
Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress
3M ago
OLMA
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3M ago
OLMA
Citi opens ‘positive catalyst watch’ on Olema Oncology into data
PremiumThe Fly
Citi opens ‘positive catalyst watch’ on Olema Oncology into data
3M ago
OLMA
Olema Oncology to Participate in Upcoming Investor Conferences in May
PremiumPress Releases
Olema Oncology to Participate in Upcoming Investor Conferences in May
3M ago
OLMA
Olema Oncology to Participate in Canaccord Genuity 2024 Horizons in Oncology Virtual Conference
PremiumPress Releases
Olema Oncology to Participate in Canaccord Genuity 2024 Horizons in Oncology Virtual Conference
4M ago
OLMA
Goldman Sachs Predicts Over 120% Rally for These 2 ‘Strong Buy’ Stocks
PremiumStock Analysis & Ideas
Goldman Sachs Predicts Over 120% Rally for These 2 ‘Strong Buy’ Stocks
4M ago
MLYS
OLMA
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress ReleasesOlema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4M ago
OLMA
Olema Oncology initiated with a Buy at Goldman Sachs
PremiumThe Fly
Olema Oncology initiated with a Buy at Goldman Sachs
4M ago
OLMA
5 Stocks that Analysts Love in March 2024
PremiumMarket News
5 Stocks that Analysts Love in March 2024
4M ago
GSK
ANAB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >